[Prevention of fetal erythroblastosis with anti-D immunoglobulin].
Rasteński
J
J
Gryglicka
M
M
D000017:ABO Blood-Group System / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000276:immunology / Q000628:therapy*; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology / Q000628:therapy*; D011295:Prenatal Care; D012203:Rh Isoimmunization / Q000276:immunology / Q000628:therapy; D012204:Rh-Hr Blood-Group System / Q000276:immunology*
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System
W sprawie profilaktyki choroby hemolitycznej za pomoca immunoglobuliny anty-D.